Skip to main content
Livermore
Livermore
ZHEN

Oncternal Therapeutics, Inc.

ONCTDelisted Mar 17, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001260990

Oncternal Therapeutics, Inc. was delisted on Mar 17, 2025; its insiders filed their last Form 4 on Jun 24, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $471.0K in total; no superinvestor held it.

13F holders, Q3 2023

Institutional positions in Oncternal Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
52
−1 vs. Q2 2023
Shares held
9.33M
−132.9K (−1.4%) vs. Q2 2023
Total value
$2.81M
−$458.2K (−14.0%) vs. Q2 2023
New holders
4
13 more added
Sold out
5
9 more reduced

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ONCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 52 institutions
Q1 2021: 67 institutionsQ2 2021: 85 institutionsQ3 2021: 77 institutionsQ4 2021: 84 institutionsQ1 2022: 79 institutionsQ2 2022: 75 institutionsQ3 2022: 61 institutionsQ4 2022: 59 institutionsQ1 2023: 55 institutionsQ2 2023: 53 institutionsQ3 2023: 52 institutionsQ4 2023: 41 institutionsQ1 2024: 24 institutionsQ2 2024: 26 institutionsQ3 2024: 23 institutionsQ4 2024: 4 institutionsQ1 2025: 0 institutionsQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 2 institutionsQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ3 2023: $2.81M
Q1 2021: $82.5MQ2 2021: $65.2MQ3 2021: $56.8MQ4 2021: $30.5MQ1 2022: $18.6MQ2 2022: $12.6MQ3 2022: $8.79MQ4 2022: $9.31MQ1 2023: $7.86MQ2 2023: $3.26MQ3 2023: $2.81MQ4 2023: $4.53MQ1 2024: $4.05MQ2 2024: $3.67MQ3 2024: $471.0KQ4 2024: $10Q1 2025: $0Q2 2025: $74Q3 2025: $73Q4 2025: $169Q1 2026: $74Q2 2026: $75
Institutions holding ONCT and their total value by quarter
QuarterHoldersValue
Q2 20261$75
Q1 20261$74
Q4 20252$169
Q3 20251$73
Q2 20251$74
Q1 20250$0
Q4 20244$10
Q3 202423$471.0K
Q2 202426$3.67M
Q1 202424$4.05M
Q4 202341$4.53M
Q3 202352$2.81M
Q2 202353$3.26M
Q1 202355$7.86M
Q4 202259$9.31M
Q3 202261$8.79M
Q2 202275$12.6M
Q1 202279$18.6M
Q4 202184$30.5M
Q3 202177$56.8M
Q2 202185$65.2M
Q1 202167$82.5M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Oncternal Therapeutics, Inc.; share changes are against Q2 2023.

Institutions holding ONCT in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc2,860,906$858.3K0.00%00.0%Unchanged
Millennium Management LLC1,647,244$499.6K0.00%+2,368+0.1%Added
BlackRock Inc.785,681$235.7K0.00%−2260.0%Reduced
Richmond Brothers, Inc.494,042$148.2K0.28%+203,010+69.8%Added
Geode Capital Management, LLC475,945$144.4K0.00%+60,361+14.5%Added
Quantum Private Wealth, LLC459,187$137.8K0.07%+3,000+0.7%Added
Brighton Jones LLC338,491$101.5K0.01%00.0%Unchanged
Renaissance Technologies LLC313,300$94.0K0.00%+26,300+9.2%Added
Pasadena Private Wealth, LLC278,750$83.6K0.03%+278,750New
LPL Financial LLC171,459$51.4K0.00%00.0%Unchanged
State Street Corp161,401$49.0K0.00%00.0%Unchanged
Ieq Capital, LLC144,434$43.3K0.00%00.0%Unchanged
Two Sigma Advisers, LP98,400$29.5K0.00%−29,500−23.1%Reduced
Morgan Stanley97,980$29.4K0.00%−70.0%Reduced
CI Private Wealth, LLC91,579$27.5K0.00%−32,614−26.3%Reduced
Northern Trust Corp84,706$25.4K0.00%00.0%Unchanged
Two Sigma Investments, LP74,681$22.4K0.00%−6,800−8.3%Reduced
Axxcess Wealth Management, LLC70,363$21.1K0.00%00.0%Unchanged
Acadian Asset Management LLC72,775$21.0K0.00%−35,192−32.6%Reduced
Regents of the University of California53,554$16.2K0.00%00.0%Unchanged
Envestnet Asset Management Inc53,911$16.2K0.00%00.0%Unchanged
Mercer Global Advisors Inc53,973$16.0K0.00%00.0%Unchanged
Balboa Wealth Partners47,500$14.3K0.01%00.0%Unchanged
Creative Planning39,318$11.8K0.00%00.0%Unchanged
Valeo Financial Advisors, LLC34,536$10.4K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc32,249$9.78K0.00%00.0%Unchanged
Beta Wealth Group, Inc.32,000$9.60K0.01%00.0%Unchanged
Aureus Asset Management, LLC30,211$9.06K0.00%00.0%Unchanged
Waypoint Capital Advisors, LLC26,271$7.88K0.00%−11,998−31.4%Reduced
Susquehanna International Group, LLP22,393$6.79K0.00%+3,673+19.6%Added
Two Sigma Securities, LLC21,224$6.37K0.00%+21,224New
JPMorgan Chase & Co20,087$6.09K0.00%+20,060+74,296.3%Added
Mackenzie Financial Corp19,944$5.99K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)19,328$5.80K0.00%−9,876−33.8%Reduced
Bank of New York Mellon Corp17,600$5.28K0.00%00.0%Unchanged
UBS Group AG13,582$4.08K0.00%+3,567+35.6%Added
Advisor Group Holdings, Inc.12,450$3.73K0.00%+988+8.6%Added
Jane Street Group, LLC10,288$3.09K0.00%−10,957−51.6%Reduced
North Star Investment Management Corp.10,000$3.00K0.00%+5,000+100.0%Added
Royal Bank of Canada10,000$3.00K0.00%+8,726+684.9%Added
Baader Bank INC10,149$2.71K0.00%+10,149New
Wells Fargo & Company6,396$1.92K0.00%+15+0.2%Added
Bank of America Corp6,000$1.80K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA3,645$1.09K0.00%00.0%Unchanged
Column Capital Advisors, LLC1,450$4350.00%00.0%Unchanged
Truvestments Capital LLC440$1320.00%00.0%Unchanged
Steward Partners Investment Advisory, LLC300$900.00%00.0%Unchanged
Lindbrook Capital, LLC300$900.00%00.0%Unchanged
Nemes Rush Group LLC71$220.00%00.0%Unchanged
Delta Asset Management LLC7$20.00%00.0%Unchanged
Qube Research & Technologies Ltd1$00.00%+1New
Coppell Advisory Solutions LLC58––+22+61.1%Added
Kennedy Capital Management, Inc.0$00.00%−587,366−100.0%Sold out
IPG Investment Advisors LLC0$00.00%−23,691−100.0%Sold out
Fort Point Capital Partners LLC0$00.00%−20,060−100.0%Sold out
Resources Investment Advisors, LLC.0$00.00%−11,731−100.0%Sold out
Rhumbline Advisers0$00.00%−50−100.0%Sold out